MedTrace Logo

Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid

NCT01559155 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2018-05-11

No results posted yet for this study

Summary

The primary objective of this study is to describe and compare plasmatic anti-proteasome auto-antibody concentrations among three distinct groups: (1) patients suffering from bullous pemphigoide; (2) patients suffering from other dermatological auto-immune diseases; (3) an elderly control group.

Conditions

  • Pemphigoid, Bullous
  • Pemphigus
  • Lupus Erythematosus, Cutaneous

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Pierre Stoebner, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-05
Primary Completion
2015-06-09
Completion
2015-06-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559155 on ClinicalTrials.gov